Assessment of efficiency of application of various analogues of insulin in treatment of diabetes type 2

Assessment of efficiency of application of various analogues of insulin in treatment of diabetes type 2

Purpose: to estimate efficiency of treatment of analogues of insulin Glargin and insulin Detemir in patients with diabetes type 2. Material and methods. 147 patients with diabetes type 2 which have been initially receiving combined therapy by oral antihyperglycemic agent and NPH-insulin have been un...

Full description

Bibliographic Details
Main Authors:	Rodionova T.l., Orlova M.M.
Format:	Article
Language:	Russian
Published:	Saratov State Medical University 2014-09-01
Series:	Саратовский научно-медицинский журнал
Subjects:	diabetes II type glycemic control insulin Detemir insulin Glargine
Online Access:	http://www.ssmj.ru/system/files/2014_03_461-464.pdf

Similar Items

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
by: Jakobsen Marie, et al.
Published: (2012-09-01)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
by: Dippel, Franz-Werner, et al.
Published: (2010-01-01)

Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats
by: Yusaku Mori, et al.
Published: (2018-05-01)

Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A 1 chieve study
by: Subhash Kumar Wangnoo, et al.
Published: (2014-01-01)

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan
by: Md Faruque Pathan, et al.
Published: (2012-01-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Basal insulin titration algorithms in patients with type 2 diabetes: the simplest is the best (?)
by: V.I. Katerenchuk
Published: (2023-03-01)

Análogos de insulina Insulin analogues
by: Manuel E. Licea Puig
Published: (2006-12-01)

Basal Insulin Initiation in Elderly Patients with Type 2 Diabetes in Taiwan: A Comparison with Younger Patients
by: Ming-Nan Chien, et al.
Published: (2015-09-01)

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol
by: Sondra Davis, et al.
Published: (2017-04-01)

CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
by: E. E. Arinina, et al.
Published: (2015-03-01)

Maternal and neonatal outcomes with the use of long acting, compared to intermediate acting basal insulin (NPH) for managing diabetes during pregnancy: a systematic review and meta-analysis
by: Jijiao Wang, et al.
Published: (2022-10-01)

Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Yunjiao Yang, et al.
Published: (2022-05-01)

Efficacy of Glargine Insulin Compared with Neutral Protamine Hagedorn Insulin in Patients with Type 2 Diabetes not Controlled with Oral Hypoglycemics: A Cohort Study
by: Ebtihal Bilal, et al.
Published: (2023-08-01)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01)

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
by: Lau IT, et al.
Published: (2017-06-01)

Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
by: Rodrigo Ribeiro e Silva, et al.
Published: (2023-06-01)

Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
by: N V Efremova, et al.
Published: (2015-10-01)

Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
by: Syed Zia Saleem, et al.
Published: (2024-04-01)

Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
by: Tamara Leonidovna Kuraeva
Published: (2014-07-01)

United States experience of insulin Degludec alone or in combination for type 1 and type 2 diabetes
by: Rendell M
Published: (2017-04-01)

Detemir potential applications in the treatment of diabetes during pregnancy: proven benefits and perspectives
by: Lyudmila A. Ruyatkina, et al.
Published: (2016-05-01)

Predictors of Glycemic Response and Change in HbA1c Following Newly Initiated Basal Insulin Among Insulin Naïve Adults With Type 2 Diabetes
by: Mojtaba Malek, et al.
Published: (2017-10-01)

Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
by: Yu Mi Kang, et al.
Published: (2019-08-01)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
by: Shafie AA, et al.
Published: (2020-06-01)

Effect of insulin glargine on glycemic control in adolescents with type 1-diabetes
by: Hassan M. Mona, et al.
Published: (2015-06-01)

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia
by: Sofie Broeng-Mikkelgaard, et al.
Published: (2023-11-01)

Clinical safety of insulin detemir in patients with Type 2 diabetes in the Gulf countries: The multicenter, noninterventional, open-label LevSafe study
by: Abdel Rahman El Shiekh, et al.
Published: (2016-01-01)

Individualisation of basal insulin therapy of type 2 diabetes: evidence from large randomized controlled trials
by: S. V. Nedogoda, et al.
Published: (2023-01-01)

Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir
by: Paweł Olczyk, et al.
Published: (2017-07-01)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
by: Le Floch J
Published: (2010-06-01)

Cost-effectiveness of intermediate or long-acting insulin versus Exenatide in type 2 diabetes mellitus patients not optimally controlled on dual oral diabetes medications
by: Edwards KL, et al.
Published: (2006-09-01)

Flexibility in insulin prescription
by: Sanjay Kalra, et al.
Published: (2016-01-01)

Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world
by: Zhang T, et al.
Published: (2018-07-01)

Análisis de costo-efectividad del uso de Detemir en pacientes con diabetes tipo 2 en riesgo de presentar eventos cardiovasculares y muerte en Colombia
by: Martín Romero Prada, et al.
Published: (2014-01-01)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
by: Trevor J. Orchard, et al.
Published: (2017-06-01)

A Pilot Study of a Comparison of Glycemic Control in Critically Ill Patients
by: Rungsun Bhurayanontachai, et al.
Published: (2010-10-01)

Insulin choice in feline diabetes mellitus
by: Yaiza Gomez Mejias
Published: (2021-08-01)

Practical Focus on American Diabetes Association/European Association for the Study of Diabetes Consensus Algorithm in Patients with Type 2 Diabetes Mellitus: Timely Insulin Initiation and Titration (Iran-AFECT)
by: Mohammad Ebrahim Khamseh, et al.
Published: (2017-01-01)